Hybrid Th1/Tfh cells have been documented in human patients with malaria (Obeng-Adjei et al., 2015) and in other persistent infections including LCMV Clone 13 (Crawford et al., 2014; Nakayamada et al., 2011) using various combinations of Th1 and Tfh markers. This evidence concerns the gene NELFCD and malaria.